74 programming-"IMPRS-ML"-"IMPRS-ML"-"IMPRS-ML" research jobs at The Ohio State University
Sort by
Refine Your Search
-
Cancer Care Program Department: CCC | Cancer Prevention Position Summary Clinical Research Assistant who provides daily operational support to the Total Cancer Care Program, TCCP, in the Comprehensive
-
Conceptualize, develop and execute an individualized training plan related to health development. Conduct research training coursework, and research activities, which may include investigator-initiated pilot
-
and adaptability are important, as staff may support studies at multiple sites based on operational needs. Additional Information: The OSUCCC – James is the only cancer program in the United States that
-
This NIH-funded program provides multidisciplinary training across the full spectrum of cancer prevention and control, including cancer risk, epidemiology (such as tobacco-related research), and health
-
: Medicine | Emergency Medicine Clinical Research Assistant serves as a health promotion advocate in the Emergency Department’s PH2S/HealthNow Program, a population health-focused program using a systemic
-
partnership with Cardinal Health, Inc. The goal of the fellowship program is to provide comprehensive postgraduate training to prepare a pharmacy fellow to design, conduct, and evaluate pharmaceutical and
-
| College Administration Conceptualize, develop and execute an individualized training plan related to health development. Conduct research training coursework, and research activities, which may include
-
Assistant serves as a health promotion advocate in the Emergency Department’s PH2S/HealthNow Program, a population health-focused program using a systemic approach to address health needs in a more proactive
-
. Yang Gao joined The Ohio State University (OSU) in August 2025 as an Assistant Professor in the Department of Cancer Biology & Genetics, where he is establishing an independent research program
-
(NCCN) Founding member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1